Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Transplantation. 2010 Mar 15;89(5):500-8. doi: 10.1097/TP.0b013e3181c73c34.
Severed donor heart lymphatics are not anastomosed to recipient lymphatics in cardiac transplantation. We evaluated the effects of cellular infiltrates of T cells and macrophages on the morphology of lymphatics in heart grafts.
Dark agouti hearts were transplanted to Lewis or control dark agouti rats on subtherapeutic doses of cyclosporin. Transplants were examined by immunohistology and quantitative immunofluorescence microscopy using lymphatic endothelial hyaluronan receptor-1 as a lymphatic marker and CD8 and CD68 as markers for cellular infiltration at selected intervals from 1 to 8 weeks posttransplantation.
Allograft inner myocardial lymphatic density decreased by more than 30-fold at 1 week and recovered to only 15% of the native level at 8 weeks posttransplantation. In contrast, allograft lymphatics in and near the epicardium showed no significant density decline but increased in size by more than 5-fold at 2 weeks, and sustained approximately 3-fold increase at 8 weeks posttransplantation. Lymphatic changes correlated temporally with the extent of T cell and macrophage infiltration in allografts, which peaked at 2 to 3 weeks posttransplantation. When grafts were retransplanted from allogeneic to isogeneic recipients at 3 weeks posttransplantation, inner lymphatic density returned close to native level within 2 weeks after retransplantation.
This is the first characterization of regional and morphologic effects of immunologic responses on heart lymphatics after transplantation. Elimination of alloimmune responses produces rapid restoration of inner lymphatic vessels, suggesting that lymphatics injured during rejection can recover when rejection is reversed during the posttransplantation course.
在心脏移植中,切断的供体心脏淋巴管不会与受体淋巴管吻合。我们评估了 T 细胞和巨噬细胞细胞浸润对心脏移植物淋巴管形态的影响。
在亚治疗剂量环孢素的情况下,将黑褐家鼠心脏移植到 Lewis 或对照黑褐家鼠体内。在移植后 1 至 8 周的选定时间点,通过免疫组织化学和定量免疫荧光显微镜检查,使用淋巴管内皮透明质酸受体-1 作为淋巴管标记物以及 CD8 和 CD68 作为细胞浸润的标记物,评估移植心脏的形态。
同种异体移植心脏内层心肌淋巴管的密度在移植后 1 周时下降了 30 多倍,在 8 周时仅恢复到原生水平的 15%。相比之下,心外膜内和附近的同种异体移植心脏淋巴管密度没有明显下降,但在 2 周时增加了 5 倍以上,并在移植后 8 周时维持了大约 3 倍的增加。淋巴管的变化与同种异体移植心脏中 T 细胞和巨噬细胞浸润的程度呈时间相关,其在移植后 2 至 3 周时达到峰值。当在移植后 3 周时将移植物从同种异体重新移植到同基因受体时,内层淋巴管密度在重新移植后 2 周内接近原生水平。
这是首次描述免疫反应对移植后心脏淋巴管的区域性和形态学影响。消除同种免疫反应会迅速恢复内层淋巴管,这表明在移植后过程中逆转排斥反应时,排斥反应期间受损的淋巴管可以恢复。